degradation of frataxin
frataxin levels
FRDA patients cells
disease causes FRDA patients
Low frataxin results
Friedreich ataxia Friedreich ataxia
mitochondrial protein frataxin
mechanism of physiological frataxin degradation
development of compounds
devastating neurodegenerative orphan disease
approved therapy
promising compounds
accelerated death of peripheral sensory neurons
mentioned ERC-funded project
tentative specific therapy
low amounts
new therapeutics
Cydan Development
project number
POC stage
patient-derived induced pluripotent stem cells
ERC Advanced Grant
new chemical entities
leading orphan drug accelerator
children
de-risking
young adults
severe disability
VC firm Kurma Partners
genetic defect
proof of concept
efficacy
normal subjects
defined path
life expectancy
Goal
original discovery
effort